Overview
The goal of this clinical trial is to evaluate the effect of a long-term, individualized, hybrid adapted physical activity program on the quality of life of patients with multiple myeloma. The main question it aims to answer are :
Does this logn term, individualized and hybrid adapted physical activity program improve quality of life in multiple myeloma patient ? What are the effects of this program on effort tolerance, pain, muscular mass, osteolytic lesions, tolerance to treatment, response to treatment? If there is a comparison group: Researchers will compare \[arm information\] to see if \[insert effects\].
Participants will be randomised in 2 groups.
- control group: patients will receive only advices about physical activities benefit
- interventional group: This group will be offered a program of adapted physical activities mixing sessions at home (remote) and sessions at the hospital (in person).
Eligibility
Inclusion Criteria:
- newly diagnosed or relapse multiple myeloma, \> 60 yo, not eligible to transplant
- 1st to 4th line of treatment initiated during the last 3 months
- receiving a systemic treatment that involved visit to the hospital at least twice a month durig the first 3 months and at least once a month the next 3 months
Exclusion Criteria:
- severe cardiac amyloidosis
- absolute contraindication to physical activity
- inability to comply with the protocol requirements
- not french speaker
- patient under guardianship or curatorship
- pregnant or lactating women
